1,2-二氢-3,3-二甲基-2-氧代-3H-吲哚 | 19155-24-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 1,2-二氢-3,3-二甲基-2-氧代-3H-吲哚
• 中文别名: 3,3-二甲基-2-氧-1,3-二氢-吲哚；1,3-二氢-3,3-二甲基-2H-吲哚-2-酮；3,3-二甲基-1,3-二氢吲哚-2-酮
• 英文名称: 3,3-dimethyloxindole
• 英文别名: 3,3-dimethyl-indol-2-one；3,3-dimethylindolin-2-one；3,3-dimethyl-1H-indol-2-one
• CAS: 19155-24-9
• 化学式: C₁₀H₁₁NO
• mdl: MFCD00158549
• 分子量: 161.203
• InChiKey: KEZHRKOVLKUYCQ-UHFFFAOYSA-N

物化性质

• 熔点：
  154.3°C
• 沸点：
  287.51°C (rough estimate)
• 密度：
  1.078

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933790090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  2-8°C

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3,3-Dimethylindolin-2-one
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3,3-Dimethylindolin-2-one
CAS number: 19155-24-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11NO
Molecular weight: 161.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1,2-二氢-3,3-二甲基-2-氧代-3H-吲哚 在 乙醚 、 五氯化磷 作用下， 生成 (3,3-二甲基-二氢吲哚-2-亚基)-苯基-胺
  参考文献：
  名称：

  800.吡啶环的​​新反应

  摘要：

  DOI：

  10.1039/jr9590003988
• 作为产物：
  描述：

  1,3,3-三甲基-2,3-二氢-1H-吲哚-2-酮 在 过氧化苯甲酰 、 sodium hydroxide 、 氨 作用下， 以 二氯甲烷 、 甲醇 为溶剂， 反应 40.0h， 以74%的产率得到1,2-二氢-3,3-二甲基-2-氧代-3H-吲哚
  参考文献：
  名称：

  通过新颖的碘化物促进的丙二烯N-酰基亚胺离子环化，首先完成ent-gelsedine的全合成。

  摘要：

  描述了从（S）-苹果酸开始的羟吲哚生物碱明胶水（1）的第一个全合成。关键步骤是丙二烯与N-酰基酰亚胺离子中间体发生的新型碘化物促进的分子内反应，该步骤在一步骤中提供了双环乙烯基碘化物11。其他重要步骤是N-甲基苯胺23a的高度立体选择性Pd催化的Heck环化通过使用二苯甲酰过氧化物的自由基机理，得到了所需的螺-羟吲哚24a，25a的完全区域选择性分子内氧合汞和所需的环醚，以及显着的羟吲哚N-脱甲基化29。通过从bis-Boc化合物41立体选择性地引入乙基，然后对羟吲哚氮进行甲氧基化，可以完成总合成。

  DOI：

  10.1021/jo001119t
• 作为试剂：
  描述：

  5-溴-3,3-二甲基-1,2-二氢吲哚 、 3-硝基苯硼酸 、 disodium;carbonate 在 四(三苯基膦)钯 1,2-二氢-3,3-二甲基-2-氧代-3H-吲哚 作用下， 以 乙二醇二甲醚 、 水 为溶剂， 以The title compound (0.17 g, 60%) was obtained as a brown semi-solid的产率得到1,2-二氢-3,3-二甲基-2-氧代-3H-吲哚
  参考文献：
  名称：

  3,3-substituted indoline derivatives

  摘要：

  本发明提供了式I的化合物：1其中：R1和R2分别为H、OH、OAc、烷基芳基、烷基杂芳基、1-丙炔基、3-丙炔基和取代烷基、O（烷基）、芳基或杂芳基；或者R1和R2结合形成包括—CH2（CH2）nCH2—的环，其中n=0-5；—CH2CH2C（CH3）2CH2CH2—；—O（CH2）mCH2—其中m=1-4；O（CH2）pO—其中p=1-4；—CH2CH2OCH2CH2—；—CH2CH2N（H或烷基）CH2CH2—；或者R1和R2一起包括双键到C（CH3）2、C（环烷基）、O或C（环醚）；R3为H、OH、NH2、CORA或者可选取代的烯基或炔基基团；RA=H或者可选取代的烷基、烷氧基或氨基烷基基团；R4=H、卤素、CN、NH2或者可选取代的烷基、烷氧基或氨基烷基；R5为可选取代的苯环、五元或六元杂环、4或7-取代吲哚或取代苯并噻吩；或其药学上可接受的盐，以及将该化合物用作孕激素受体拮抗剂的药物组合物和方法。

  公开号：

  US20030008909A1

文献信息

• A general N-alkylation platform via copper metallaphotoredox and silyl radical activation of alkyl halides
  作者：Nathan W. Dow、Albert Cabré、David W.C. MacMillan

  DOI：10.1016/j.chempr.2021.05.005

  日期：2021.7

  The catalytic union of amides, sulfonamides, anilines, imines, or N-heterocycles with a broad spectrum of electronically and sterically diverse alkyl bromides has been achieved via a visible-light-induced metallaphotoredox platform. The use of a halogen abstraction-radical capture (HARC) mechanism allows for room temperature coupling of C(sp3)-bromides using simple Cu(II) salts, effectively bypassing

  通过可见光诱导的金属光氧化还原平台实现了酰胺、磺胺、苯胺、亚胺或N-杂环与广谱电子和空间多样化烷基溴的催化结合。卤素提取-自由基捕获 (HARC) 机制的使用允许使用简单的 Cu(II) 盐在室温下耦合 C( sp 3 )-溴化物，有效绕过通常与热诱导 S N 2 或 S相关的过高障碍N 1 N-烷基化。这种区域和化学选择性方案与 >10 类药物相关的N兼容- 亲核试剂，包括已建立的药剂，以及结构多样的伯、仲和叔烷基溴。此外，通过将N-亲核试剂与环丙基溴和未活化的烷基氯（与亲核取代途径不相容的底物）结合，突出了 HARC 方法与传统惰性偶联伙伴结合的能力。初步的机械实验验证了该平台的双重催化、开壳性质，这使得在传统的基于卤化物的N-烷基化系统中无法实现的反应性成为可能。
• [EN] A THIONATION PROCESS AND A THIONATING AGENT<br/>[FR] PROCÉDÉ DE THIONATION ET AGENT DE THIONATION
  申请人：VIRONOVA AB

  公开号：WO2012104415A1

  公开（公告）日：2012-08-09

  A process for transforming a group >C=O (I) in a compound into a group >C=S (II) or into a tautomeric form of group (II) in a reaction giving a thionated reaction product, by use of crystalline P2S5·2 C5H5N as a thionating agent. A thionating agent which is crystalline P2S5·2 C5H5N

  将化合物中的一个羰基团（I）转化为一个硫代羰基团（II）或在给出硫代反应产物的反应中将其转化为羰基团（II）的互变异构形式的过程，通过使用晶体P2S5·2 C5H5N作为硫代试剂。一种晶体P2S5·2 C5H5N作为硫代试剂
• MULTIFUNCTIONAL SMALL MOLECULES
  申请人：The Regents of the University of Michigan

  公开号：US20150216993A1

  公开（公告）日：2015-08-06

  The present invention relates to novel therapeutic dendrimer conjugates configured for the treatment and/or prevention of organophosphate poisoning. In particular, the present invention is directed to dendrimers complexed with organophosphate poisoning antidotes (e.g., pralidoxime (2-PAM) (4-PAM), obidoxime, trimedoxime, asoxime (HI-6), hydroxamate, and related analogs, salts and derivatives thereof), compositions comprising such dendrimer conjugates, related methods of synthesizing such dendrimer conjugates, as well as systems and methods utilizing such dendrimer conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in the treatment and/or prevention of organophosphate poisoning)).

  本发明涉及用于治疗和/或预防有机磷酸盐中毒的新型治疗性树状大分子偶联物。特别是，本发明涉及与有机磷酸盐中毒解毒剂（例如，普瑞洛霉素（2-PAM）（4-PAM），奥比多西姆，三甲多西姆，阿索西姆（HI-6），羟基酰胺以及相关的类似物，盐和衍生物）复合的树状大分子，包含这样的树状大分子偶联物的组合物，合成这样的树状大分子偶联物的方法，以及利用这样的树状大分子偶联物（例如，在诊断和/或治疗环境中（例如，用于治疗剂，成像和/或靶向剂（例如，在治疗和/或预防有机磷酸盐中毒）的递送））的系统和方法。
• [EN] FURO[3,2-d]PYRIMIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE FURO[3,2-D]PYRIMIDINE
  申请人：ABBOTT LAB

  公开号：WO2012048222A1

  公开（公告）日：2012-04-12

  The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.

  本发明涉及式(I)的新化合物、药用可接受的盐、生物活性代谢物、前药、外消旋混合物、对映异构体、非对映异构体、溶剂合物和水合物，其中变量如本文所述定义。式(I)的化合物作为激酶抑制剂是有用的，因此可用于治疗某些状况和疾病，特别是炎症状况和疾病以及增殖性障碍和状况，例如癌症。
• LXR AGONISTS AND USES THEREOF
  申请人：Martinez Eduardo J.

  公开号：US20170066791A1

  公开（公告）日：2017-03-09

  This invention features compounds that modulate the activity of liver X receptors, pharmaceutical compositions including the compounds of the invention, and methods of utilizing those compositions for modulating the activity of liver X receptors in the treatment of cancer.

  这项发明涉及调节肝X受体活性的化合物，包括该发明的化合物的药物组合物，以及利用这些组合物调节肝X受体活性治疗癌症的方法。